PhenoBiome Welcomes New Leadership and Validates Breakthrough Microbiome
Modulation
PALM SPRINGS, March 25, 2025
PhenoBiome, Inc., a pioneering leader in personalized microbiome solutions, today announced the
appointment of Brian Russon as Chief Executive Officer (CEO) and Kait Mikes as Chief Operating Officer
(COO). Didier Perez, who previously served as CEO, will continue with the leadership team focused on
strategic business development. This leadership transition will position PhenoBiome for
accelerated growth and market expansion. Concurrently, PhenoBiome’s breakthrough clinical
trial confirms the effectiveness of its advanced in silico phenotype platform in delivering realworld
improvements in gut health.
see more...
PhenoBiome Announces Breakthrough Clinical Trial Validating Predictive
Microbiome Modulation
SAN FRANCISCO, February 21, 2025
Phenobiome, a leader in precision microbiome technologies, today announced the successful completion
of a clinical trial demonstrating its advanced in silico phenotype platform's ability to drive
real-world
improvements in gut health. The study, conducted over 60 days with 30 participants, evaluated the impact
of personalized
prebiotic and micronutrient formulations on gut microbial composition and metabolic function.
see more...
Unlocking the Mystery of Gut Health
July 10, 2023
Zoom Meeting ID: 895 3375 8879
Join us and our guest speaker, Dr.
Jessica Knurick, PhD, RDN, who is one
of the key architects of the GxGutHealth microbiome report, for an engaging
and informative webinar as we explore the fascinating
world of gut health and the power of microbiome testing. In this webinar, we will dive deep into the
intricacies of the gut microbiome
and how it influences our overall health and well-being. Discover the cutting-edge technology and
innovative insights
offered by GxGutHealth, a
personalized
microbiome test developed by our partner company, PhenoBiome (who developed the science behind the test
with over a decade of
gut health research) and offered by Genetic Direction to our affiliates & partners.
VIDEO: Unlocking the Mystery of Gut Health
PhenoBiome launches human gut microbiome assay with Genetic Direction
SAN FRANCISCO, Sept. 23, 2021
PhenoBiome today announced it will launch its first human gut microbiome assay through Genetic
Direction, a Dallas-based distributor of genetics-based health management programs. Clinical Enterprise,
Inc., a Eurofins Scientific company, will process the assays in its CLIA- and CAP-certified laboratory.
see
more...
Overcoming Obesity 2021 Conference
Chicago, IL, Sept. 23-26, 2021
See us at Booth 217 see more...